Tristetraprolin (TTP) has been reported to promote rapid mRNA decay [14] and is involved in COX-2 downregulation in colon cancer cells, driving COX-2 mRNA for rapid degradation [13,15]. The gene discussed is PTGS2; the disease is malignant colon neoplasm.